FDA Inspection
United States Global PartnersUnited States Global Partners – FDA Inspection, Jan 24, 2020
Record Details
This FDA Inspection record concerns United States Global Partners, with an inspection on January 24, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 24, 2020
- Product Type
- Biologics
View Company Profile
ID · 2f8c3963-050c-4f83-bcfa-50f1697bbf36
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1116223
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.260(e)Storage temperatures recorded, maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of United States Global Partners
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for United States Global Partners
- FDA Inspection 1050589 - 2018-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.